# Uterotonics Using to Reduce Bleeding at Cesarean Section

> **NCT02562300** · PHASE2 · COMPLETED · sponsor: **Assiut University** · enrollment: 120 (actual)

## Conditions studied

- Postpartum Haemorrhage

## Interventions

- **DRUG:** Misoprostol
- **DRUG:** Oxytocin

## Key facts

- **NCT ID:** NCT02562300
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2015-01
- **Final completion:** 2015-04
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2020-08-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02562300

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02562300, "Uterotonics Using to Reduce Bleeding at Cesarean Section". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02562300. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*